Dudediligence.

Alaunos Therapeutics, Inc

TCRTNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$4,000Dec ’24$2,000Mar ’25$0.00Jun ’25$0.00Sep ’25$3,000Dec ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$1.1MSep ’24−$742,000Dec ’24−$1.1MMar ’25−$1.1MJun ’25−$1.2MSep ’25−$893,000Dec ’25−$1.0MMar ’26−$952,000Jun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$398,000$2.9M$5,000$10,000$5,000
Operating income−$77.5M−$35.1M−$34.3M−$4.8M−$4.2M
Net income−$78.8M−$37.7M−$4.7M−$4.7M−$4.2M
Operating cash flow−$61.5M−$29.2M−$30.1M−$5.0M−$2.9M
Free cash flow−$64.8M−$29.4M−$30.3M−$5.0M−$3.0M
Cash$76.1M$39.1M$6.1M$1.1M$1.4M
Debt$24.1M$16.8M$0.00$0.00none on file
Shares outstanding216.1M16.0M1.6M1.6M2.3M